Objectives: Bloodstream infections (BSI) are a serious cause of morbidity and mortality worldwide. Emerging antimicrobial drug resistance among bacterial pathogens causing BSI can limit therapeutic options and complicate patient management. This retrospective study was conducted to determine trends in Salmonella BSI and antibiotic susceptibility patterns over 6 years (2008e2013) in a tertiary care hospital in Dhaka, Bangladesh. Methods: A total of 3584 blood samples were collected from patients with clinically diagnosed enteric fever at Dhaka Medical College Hospital, Dhaka from January 2008 to December 2013. Isolates of Salmonella enterica serovars Typhi and Paratyphi were identified by standard microbiological and biochemical procedures. Results: A total of 168 isolates of S. enterica serovar Typhi and 160 isolates of S. enterica serovar Paratyphi were found. The average prevalence rate of Salmonella in the blood was 9.15%. Young patients, neonates, and elderly individuals were more prone to Salmonella infection than other patients, and females were more susceptible to Salmonella septicemia than males. Among Salmonella spp. isolates, 20.92% were multidrug resistant and showed high resistance against amoxicillin, trimethoprimesulfamethoxazole, ciprofloxacin, nalidixic acid, and chloramphenicol. Resistance rates to cefipime, cefixime, and ceftriaxone are increasing slowly. Among Salmonella spp. isolates, 57.01% showed extended-spectrum b-lactamase production capability. Conclusion: Specific antibiotic utilization strategies such as antibiotic restriction, combination therapy and usage according to standard antimicrobial susceptibility testing may help decrease or prevent the emergence of resistance and incidence of BSI.
Introduction
Salmonella is an enteropathogenic microorganism that causes infection accompanied by different clinical manifestations, most commonly gastroenteritis and fever [1] . Salmonella bloodstream infections (BSI) represent a major health problem worldwide but particularly in developing countries such as Bangladesh [2e5] . Each year, there are 12e33 million cases of typhoid fever worldwide. BSI cause significant morbidity and mortality worldwide and are among the most common health care-associated infections [6] . Microorganisms present in circulating blood, whether continuously or intermittently, are a threat to every organ in the body. Illnesses associated with BSI range from self-limiting infections to lifethreatening sepsis that requires rapid and aggressive antimicrobial treatment [7] .
Treatment of Salmonella infection has become challenging because of emerging antibiotic resistance to first-line antibiotics such as chloramphenicol, ampicillin, sulphamethoxazoletrimethoprim, and, more recently, the fluoroquinolones [8] . The emergence of multidrug resistant (MDR) Salmonella strains with resistance to fluoroquinolones and third-generation cephalosporins is a serious problem that results in severe limitation of the possibilities for effective treatment of human infections [9, 10] . The appearance of MDR Salmonella enterica serovar Typhi (SEST) has resulted in a pressing need to test newer antimicrobials, develop their dose regimens for the treatment of typhoid fever [11] , and find the mechanism by which they acquire resistance [12] .
Nowadays, bacterial drug resistance is an important problem. Because of the wide variations in this resistance, the results of studies and reports in one region or in one period of time are not necessarily true for other regions or periods of time [13] . Drug resistance is related to a series of social, environmental, and technological changes. Because of constantly evolving antimicrobial resistant patterns, there is need for constant antimicrobial sensitivity surveillance [14] . The determination of antibiotic sensitivity patterns at periodic intervals is mandatory in each region for clinicians to be aware of emerging pathogens that pose a threat to the community, provide safe and effective empirical therapies, develop rational prescribing practices and policy decisions in a hospital and finally assess the effectiveness of all [15] . Appropriate surveillance by monitoring antimicrobial drug susceptibility trends is a prerequisite to implementing rational measures to tackle the resistance problem [16] .
The aim of our study was to assess the prevalence of Salmonella serotypes in a tertiary care hospital in Dhaka, Bangladesh. We determined the predominant serotypes and resistance profiles of Salmonella spp. strains isolated from patients over a period of 6 years (2008e2013) at a hospital that receives patients from different parts of the country.
Materials and methods

Duration and place of study
This study was conducted on 3584 samples of blood collected from patients with clinically diagnosed enteric fever at Dhaka Medical College Hospital, Dhaka from January 2008 to December 2013. Blood samples were collected from patients suspected of having septicemia and typhoid fever admitted to Dhaka Medical College Hospital. The age of the patients in this study ranged from 2 years to 61 years. The population under study included both male and female patients. With the permission of the hospital authority and institutional ethical review committee, informed consent was obtained from each participant. In the case of young patients (<20 years), consent was obtained from parents/legal guardians.
Collection of blood samples
The skin at the venipuncture site of the patient was first cleaned with 95% alcohol. A 10 mL sample of blood was drawn into a 10 mL disposable pyrogen free syringe. A 5 mL sample of blood was inoculated into a blood culture bottle containing 45 mL of braineheart infusion broth. These bottles were immediately transported to the laboratory [17] .
Isolation of S. enterica serovars
Blood cultures bottles were incubated aerobically at 37 C for 1 week. These bottles were examined daily throughout the week of incubation. When growth appeared on any of the medium, a Gram stain film was made. If Gram-negative bacilli were detected, the culture from the blood culture bottle was inoculated onto a blood agar, xylose lysine deoxycholate agar, and a MacConkey's agar plate [10] .
Biochemical identification of serovars
The API 20E identification system was used for biomedical identification of SEST and Salmonella enterica serovar Paratyphi (SESP). The system consists of a plastic strip with 20 microtubes containing dehydrated substrate of orthonitrophenylgalactopyranoside. The incubation box was prepared by putting 5 mL of sterile water into the honeycombed wells of the tray to create a humid chamber. The strip was then place in the tray. A single isolated colony of suspected Salmonella was picked up from MacConkey's plate. It was emulsified in sterile saline to achieve a homogenous bacterial suspension. With a sterile pipette, the tubes and cupules of citrate, VogeseProskauer and gelatin were filled with bacterial suspension. The remaining tubes and cupules were filled with bacterial suspension. An anaerobic environment was created in the arginine dihydrolase, lysine decarboxylase, ornithine decarboxylase, urease, and hydrogen sulfide tests by overlaying with mineral oil. The box was closed and incubated at 37 C for 24 hours. A MacConkey agar plate was inoculated with the same homogenous bacterial suspension to check the purity of the bacterial suspension and incubated at 37 C for 24 hours.
Serological identification of SEST and SESP
Anti-Salmonella agglutinating sera contain SEST and SESP A, SESP B, SESP C, and SESP Vi from BioM erieux (Marcy l' Etoile, France) were used. The Kauffmann and White scheme was followed for serological confirmation of SEST and SESP. One drop of agglutinating serum was placed on a clean glass slide. One colony of the test strain of Salmonella was picked up with a loop from the Mac-Conkey agar plate. This bacterial culture and agglutinating serum were mixed slowly with a sterile stick. When fully mixed, the slide was rotated for 5e10 seconds. The agglutination was examined by the naked eye. Positive and negative controls were tested in a similar way on the same slide [18] .
Antibiotic susceptibility testing
All the Salmonella spp. (328) strains were tested for antibiotic resistance by the standard agar disc diffusion technique [19] on MuellereHinton agar (HiMedia Laboratories Pvt. Ltd., Mumbai, India) using commercial discs (Oxoid, Basingstoke, Hampshire, UK). The following antibiotics with the disc strength in parentheses were used: amoxicillin (10 mg), ciprofloxacin (5 mg), cefipime (30 mg), ceftriaxone (30 mg), cefixime (5 mg), chloramphenicol (50 mg), meropenem (10 mg), trimethoprimesulfamethoxazole (25 mg), and nalidixic acid (30 mg). A control strain of Escherichia coli ATCC 25922 was included in each plate. Antimicrobial breakpoints and interpretations were taken from standards of the Clinical and Laboratory Standards Institute [20] . Isolates resistant to three or more drugs were classified as MDR.
Detection of extended-spectrum b-lactamase by the double disc diffusion method
Positive (Klebsiella pneumoniae ATCC 700603) and negative (E. coli ATCC 25922) control strains were inoculated onto Mul-lereHinton agar. An amoxicillineclavulanic acid (20 mg and 10 mg) disc was placed on the center of the plate. Ceftazidime (30 mg), ceftriaxone (30 mg), cefotaxime (30 mg), and aztreonam (30 mg) discs were placed peripherally away from the amoxicillinclavulanic acid disc. After 24 hours of incubation at 37 C, band formation between the amoxicillin clavulanic acid disc and any other disc was considered extended-spectrum b-lactamase (ESBL) positive. The ESBL positive strains were further subjected to phenotypic confirmatory tests using sensitivity discs, which contained third-generation cephalosporins both with and without clavulanic acid. The discs used included cefotaxime (30 mg), cefotaxime and clavulanic acid (30 mg and 10 mg), ceftazidime (30 mg), ceftazidime (30 mg and 10 mg), aztreonam (10 mg), and aztreonam and clavulanic acid (30 mg and 10 mg). The differences in the zones of inhibition caused by the cephalosporins alone and those combined with clavulanic acid were recorded and, if the difference was 5 mm or more, the strains were confirmed as ESBL-producing strains [21] .
Results
Patient information
A total of 3584 patient blood samples were collected from 2008e2013. Of these 1465 (40.87%) were from male patients and 2119 (59.13%) were from females. The age distribution showed that young children, neonates, and elderly patients were almost equally susceptible to Salmonella infection in the blood. It is likely that their immune systems are weaker than healthy adults and thus they are prone to septicemia. The highest percentage of all patients with clinically diagnosed enteric fever were in the 20e35 year age group (29.19%), followed by the 36e50 year age group (26.62%) ( Table 1) . Treatment histories of all enteric fever patients showed that the highest percentage were from the gynecology department (26.4%) followed by medicine (19.89%), pediatrics (13.53%), surgery (8.34%), and outpatient (17.91%) departments ( Table 1 ). The age, sex, and department of patients with Salmonella spp. in the bloodstream are also shown in Table 1 .
Isolation and biochemical and serological identification of Salmonella spp.
A total of 328 samples of Salmonella were isolated and identified biochemically from 3584 blood samples. All the isolates showed negative results in the ortho-nitrophenyl-b-galactoside, arginine dihydrolase, citrate, urease, tryptophane deaminase, indole, VogeseProskauer, gelatine, inositol, saccharose, and amylose tests, and positive results in the lysine decarboxylase, ornithine decarboxylase, urease, hydrogen sulfide H 2 S, glucose, mannose, sorbose, rhaffinose, mellibiose, and arabinose tests. In serology, 168 isolates agglutinated with SEST polyvalent antisera and 160 isolates with SESP polyvalent antisera, confirming their identity.
Rates of SEST and SESP isolated from blood cultures
Distribution of illness by month and Salmonella prevalence are shown in Table 2 . Salmonella spp. were isolated throughout the year, but the prevalence was comparatively low in the first half (JanuaryeJune) of the year. The prevalence showed a peak during July, August, and September ( Table 2) .
The prevalence of Salmonella spp. from 2008 to 2013 showed a gradual increase although the prevalence in 2010 (8.65%) and 2011 (8.18%) was slightly lower than in 2012 (9.2%) and 2013 (11.41%; Fig. 1 ). Overall prevalence of Salmonella spp. in blood samples from 2008e2013 was 9.15%.
In 2008, there were fewer SEST isolates than SESP (Fig. 2) , but from 2009e2013, an increasing pattern of SEST isolates was observed. In 2013, there were more SEST isolates (n ¼ 39) than SESP (n ¼ 33). (Fig. 3) .
Sensitivity/resistance of Salmonella isolates to antimicrobial compounds
Comparison of antibiotic resistance showed relatively higher resistance in S. paratyphi isolates than S. typhi ( Figs. 4 and 5 ). Both groups of organism showed higher resistsance to amoxicillin, trimethoprimesulfamethoxazole, ciprofloxacin, nalidixic acid, and chloramphenicol than to other antibiotics. Resistance to fluroquinolones such as cefipime, cefixime, and ceftriaxone increased over the time studied. No resistance was observed against meropenem.
MDR Salmonella patterns in blood cultures
MDR was found in 20.96% of Salmonella spp. isolates in total. MDR rates in 2008 were 22.56%; in 2009, 19.14%; in 2010, 22.1%; in 2011, 18.41%; in 2012, 16.25%; and 27.31% in 2013 (Fig. 6) .
The distribution of MDR Salmonella spp. in blood cultures by month is shown in Table 3 .
ESBL production
ESBL production was found in 57.01% of all Salmonella spp. isolates, 54.17% of SEST isolates, and 60.625% of SESP isolates (Fig. 7) .
Discussion
Typhoid fever caused by SEST and SESP is one of the most common infections in Bangladesh [22] . Strains of SEST and SESP resistant to commonly used antibiotics such as chloramphenicol, amoxicillin, trimethoprimesulfamethoxazole, and ciprofloxacin are emerging in many parts of the world including Bangladesh [23] . Emerging antimicrobial drug resistance among bacterial pathogens causing BSI can limit therapeutic options and complicate patient management. The epidemiology of invasive bloodstream pathogens has changed dramatically over the years [24] . The changes in the incidence and epidemiology of infecting organisms have also brought about an increase in resistance to many antibiotic compounds, resulting in a reduction in therapeutic options [25] . Septicemia is one of the most severe invasive bacterial infections and surveillance of antibiotic susceptibility of the organisms isolated from blood cultures is an important method of obtaining information on resistance patterns at the regional and national level. Because of variations in the susceptibility patterns of Salmonella species from different geographical areas, constant monitoring is important to provide suitable guidelines for successful treatment.
This study was carried out to show the antibiotic susceptibility patterns of Salmonella strains (SEST and SESP) isolated from the blood of typhoid patients in a tertiary care hospital in Dhaka, Bangladesh. About 9.15% of the total samples were positive for Salmonella spp. The prevalence increased gradually from 2008 to 2013 in accordance with other studies [26, 27] . SEST (168 samples) was more prevalent than SESP (160 samples). Salmonella infection occurred throughout the year but the highest prevalence was found in JulyeDecember.
Neonates and young (age 2e15 years) and elderly persons (age 46e60 years) were more susceptible to Salmonella infection, probably because of their weaker immune systems. Healthy adults are less susceptible to BSI with Salmonella. Females had more infections than males and the same pattern was observed in Salmonella spp., SEST, and SESP infections.
A high percentage of the isolates showed resistance to first line (amoxicillin, chloramphenicol, trimethoprimesulfamethoxazole) and second line drugs (nalidixic acid and ciprofloxacin). Resistance to cephalosporins such as cefipime, cefixime, and ceftriaxone tended to increase during this period. No resistance was observed against meropenem. Many researchers around the world have reported increased resistance of Salmonella spp. against nalidixic acid [28, 29] and a dramatic increase in nalidixic acid-resistant isolates was observed in this study.
Several previous studies reported bloodstream Salmonella spp. in patients from Bangladesh. In one study [23] , 66% of patients were Salmonella spp. positive and one third of the isolated S. typhi were MDR. The isolates were most resistant to amoxicillin, cotrimoxazole, and chloramphenicol. In another study [30] , among 304 of 385 (79%) isolated Salmonella spp. were S. typhi and 81 (21%) were S. paratyphi. About 40% of the S. typhi isolates were resistant to ampicillin, chloramphenicol, and co-trimoxazole compared with only 1.8% of SESP. All SEST and SESP A were sensitive to ceftriaxone [31] . Twelve MDR Salmonella isolates from hospital waste were resistant to ciprofloxacin, ampicillin, amoxicillin, and penicillin. The Table 2 Month-wise distribution of illness and organisms during 2008e2013.
Parameter
Month Total   Jan  Feb  Mar  Apr  May  Jun  Jul  Aug  Sep  Oct  Nov  Dec   2008  Febrile Illness  19  29  27  46  39  45  77  91  55  29  19  23  499  Salmonella spp.  2  2  2  3  2  3  8  11  5  3  2  3  46  SEST  0  1  1  1  0  1  4  6  2  2  1  1  20  SESP  2  1  1  2  2  2  4  5  3  1  1  2  26  2009  Febrile Illness  21  32  29  45  39  55  88  97  55  33  37  21  552  Salmonella spp.  0  3  2  3  2  3  9  12  5  3  2  3  47  SEST  0  1  1  1  0  1  6  8  4  2  1  0  25  SESP  0  2  1  2  2  2  3  4  1  1  1  3  22  2010  Febrile Illness  45  33  21  35  29  45  99  105  65  40  47  19  583  Salmonella spp.  3  0  2  2  4  3  11  13  7  3  2  3  53  SEST  1 presence of MDR Salmonella in hospital waste indicates BSI of patients with Salmonella. In another study, 943 SEST were isolated from patients with typhoid fever and >50% of isolates were resistant to ampicillin, co-trimoxazole, and chloramphenicol, and >90% of isolates were resistant to nalidixic acid. Resistance to ciprofloxacin was very low [32] . Similar results were also found in another study [33] where resistance was higher to ampicillin, cotrimoxazole, and chloramphenicol and all isolates were sensitive to ceftriaxone and ceftazidime.
Most of the previous studies in Bangladesh on bloodstream Salmonella spp. did not report detection of MDR Salmonella but in this study, 20.92% of isolates were MDR. From 2008 to 2012, MDR isolates decreased but in 2013 a sudden rise in the percentage of MDR isolates was observed (Fig. 6 ). The distribution of MDR isolates by month showed a higher prevalence from July to October each year ( Table 2) , which is in accordance with the higher prevalence of Salmonella spp. from July to December each year in this study (Table 3 ). In one study [29] , MDR Salmonella spp. prevalence was 37%, which is higher than in the present study. Mohanty et al [34] also reported an increasing pattern of MDR Salmonella spp. in BSI.
In this study, ESBL production was observed in 57.01% of all Salmonella spp. isolates, 54.17% of SEST isolates and 60.625% of SESP isolates (Fig. 7) . ESBL production was higher in this study than in some previous studies. Irajian et al [35] reported ESBL production in 2% of SESP. This indicates an increasing trend of ESBL production in bloodstream Salmonella spp. isolates in Bangladesh. ESBL Salmonella spp. in a hospital setting is a challenge because of possible spread of ESBL to other opportunistic pathogens and because of the limited therapeutic options against them.
This study in conjunction with previous studies warns about the increasing prevalence of Salmonella BSI in a wide group of patients and their increased resistance to first line and second line drugs of choice. Although the mortality rate linked to salmonellosis is low, its high prevalence has significant economic, epidemiological, and health implications. Our data underscore the need for annual antimicrobial resistance surveillance reports, which can provide valuable insight into resistance trends at a particular medical facility to assist in the appropriate choice of empiric therapy.
Accurate prevalence rates and antibiotic resistant patterns of bloodstream Salmonella spp. in Bangladesh cannot be ascertained because of a lack of epidemiological surveillance systems at all levels of government (federal, state, and local), and the presence of other diseases considered to be of higher priority [11] . The selective pressure of unrestricted antimicrobial usage has probably contributed to the genesis of resistant SEST [36] . In Dhaka, antimicrobials are available from chemist shops without legal prescriptions. This encourages patients to buy antimicrobials over the counter and use them without consulting a doctor. Appropriate surveillance by monitoring antimicrobial drug susceptibility trends is a prerequisite to implementing rational measures to tackle the resistance problem. Continued surveillance of antimicrobial susceptibility patterns and study of MDR in Salmonella spp. in different parts of the country will help in updating knowledge about the proper antibiotics for therapeutic cure.
Conclusion
This study provided much needed information and warns about the increasing prevalence of MDR SEST and SESP causing BSI in Bangladesh. The rise in antibiotic resistance in blood isolates emphasizes the importance of sound hospital infection control, rational prescribing policies, and the need for new antimicrobial drugs and vaccines. Our data underscore the need for annual antimicrobial resistance surveillance reports, which can provide valuable insight into resistance trends at a particular medical facility to assist in the appropriate choice of empiric therapy.
